Huntington’s disease research news.
In plain language. Written by scientists.
For the global HD community.
Dimebon fails to improve symptoms in HD patients in the HORIZON trial
Dimebon – disappointing results in an Alzheimer’s disease trial, but hope remains for HD.
New to HD research? Click here to get an overview
A Freedom Tower on Chromosome Five
Subscribe in iTunes
Podcast RSS Feed
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can't promise to write content about any particular suggestion.